Votavova, H.; Urbanova, Z.; Kundrat, D.; Dostalova Merkerova, M.; Vostry, M.; Hruba, M.; Cermak, J.; Belickova, M.
Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients. Pharmaceuticals 2021, 14, 41.
https://doi.org/10.3390/ph14010041
AMA Style
Votavova H, Urbanova Z, Kundrat D, Dostalova Merkerova M, Vostry M, Hruba M, Cermak J, Belickova M.
Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients. Pharmaceuticals. 2021; 14(1):41.
https://doi.org/10.3390/ph14010041
Chicago/Turabian Style
Votavova, Hana, Zuzana Urbanova, David Kundrat, Michaela Dostalova Merkerova, Martin Vostry, Monika Hruba, Jaroslav Cermak, and Monika Belickova.
2021. "Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients" Pharmaceuticals 14, no. 1: 41.
https://doi.org/10.3390/ph14010041
APA Style
Votavova, H., Urbanova, Z., Kundrat, D., Dostalova Merkerova, M., Vostry, M., Hruba, M., Cermak, J., & Belickova, M.
(2021). Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients. Pharmaceuticals, 14(1), 41.
https://doi.org/10.3390/ph14010041